Manchester Capital Management’s Haemonetics HAE Stock Holding History

Manchester Capital Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3	Closed	–	–	699
2020 Q4	$0	Buy	+3	New	+$323	﹤0.01%	762
2016 Q1	–	Sell	-1,300	Closed	-$42K	–	629
2015 Q4	$42K	Hold	1,300	–	–	0.01%	476
2015 Q3	$42K	Buy	+1,300	New	+$48.9K	0.01%	452
2015 Q1	–	Sell	-1,600	Closed	-$60K	–	681
2014 Q4	$60K	Sell	1,600 -1,600	-50%	-$58.6K	0.01%	678
2014 Q3	$112K	Hold	3,200	–	–	0.02%	531
2014 Q2	$113K	Buy	+3,200	New	+$107K	0.02%	528
2014 Q1	–	Sell	-8,310	Closed	-$350K	–	1000
2013 Q4	$350K	Buy	8,310 +300	+4%	+$12.3K	0.05%	205
2013 Q3	$319K	Buy	8,010 +6,710	+516%	+$282K	0.05%	225
2013 Q2	$54K	Buy	+1,300	New	+$52.6K	0.01%	580

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Manchester Capital Management's HAE Position: Q1 2021 in Review

Manchester Capital Management sold out of Haemonetics (HAE) in Q1 2021, closing a stake of 3 shares.

Manchester Capital Management first reported a position in HAE in Q2 2013 and held it in 9 quarters. The position peaked at $350K in Q4 2013. 296 funds tracked by Wall St. Rank hold HAE as of Q1 2021.

Manchester Capital Management reported no remaining Haemonetics position as of Q1 2021 after selling out during the quarter.
Manchester Capital Management sold 3 Haemonetics shares in Q1 2021.
Manchester Capital Management first reported a position in Haemonetics in Q2 2013 and held it in 9 quarters.
Manchester Capital Management's Haemonetics position peaked at $350K in Q4 2013.
296 funds tracked by Wall St. Rank held Haemonetics as of Q1 2021.

Based on Manchester Capital Management's 13F filing for Q1 2021, filed 13 May 2021.